Different sources establish different things
The archive includes outcome research, authored analysis, conference abstracts, patent applications, government records, independent reporting, and market context. Each type supports a different claim. A trial can support a result for a defined population; a patent application can establish inventor attribution and a dated design; a government record can establish participation or recognition.
Kevin’s career account supplies additional operating responsibilities and organizational details. Those are labeled as career records rather than presented as independently verified by an unrelated public link.
Diabetes Care, 2012
Kevin is a co-author of Integrating an Automated Diabetes Management System into the Family Management of Children with Type 1 Diabetes: Results from a 12-Month Randomized Controlled Technology Trial. The study followed 48 children and evaluated automated glucose-data collection and family feedback. It provides a specific outcome-research anchor for the Diabetech story.
The archive links the full article and DOI. Readers should use the original paper for study design, endpoints, statistical results, and limitations.
Diabetes Spectrum, 2013
Kevin authored Power and Pitfalls of Social Media in Diabetes Care. The article examines patient information and support in relation to clinical workflow and the risks of unreliable advice. It connects his technology and community experience to a professional discussion of how healthcare teams can engage with patient information networks.
Kaiser and rare-disease abstracts
The 2010 Diabetes Social Support Feasibility Pilot Study abstract includes Kevin in its author group. It supports his contribution to technology-mediated social support research. Related Roblin publications and an AHRQ-hosted presentation supply additional context but are not all represented as Kevin-authored works.
The 2021 ACMG supplement includes the LC-FAOD disease-monitoring-program abstract eP029, also listing Kevin as an author. This is public evidence for his rare-disease research contribution. It is an abstract rather than a full treatment-outcomes publication.
Technical and public records
US20050038680A1 names Kevin as inventor and dates the remote monitoring architecture to the early 2000s. The archive identifies it as a patent application and does not claim it is an active granted patent. D CEO and David Mendosa reporting describe Diabetech and GlucoMON during their early commercial period. Texas government documents add recognition and policy-participation context.
The separate publication index provides the original links, source descriptions, and distinctions between direct evidence and contextual material.
Sources and record basis
- Peer-reviewed researchDiabetes Care · 2012 randomized controlled trial
A 12-month study of 48 children evaluated automated glucose-data collection and family feedback. Kevin McMahon is a co-author. The findings concern the intervention studied; they are not a claim about every later product.
- Publication identifierDiabetes Care · DOI 10.2337/dc11-1597
Persistent identifier for the randomized controlled technology trial.
- Authored articleDiabetes Spectrum · Power and Pitfalls of Social Media in Diabetes Care
Kevin L. McMahon’s 2013 article addresses patient information, peer support, clinical workflow, and the risks of unreliable health advice.
- Conference abstractClinical Medicine & Research · 2010 journal issue and pilot abstract
Contains the Diabetes Social Support Feasibility Pilot Study abstract, including Kevin McMahon in the author group. The link opens the journal issue.
- Conference abstractMolecular Genetics and Metabolism · ACMG 2021 supplement, eP029
The LC-FAOD disease-monitoring-program abstract lists Kevin McMahon among its authors. It is a conference abstract in an indexed supplement, not a full outcomes paper.
- Patent applicationGoogle Patents · US20050038680A1
Names Kevin McMahon as inventor. Priority: December 19, 2002; filing: February 3, 2004; publication: February 17, 2005. The publication documents an architecture; it is not presented as an active granted patent.
- Independent reportingD CEO · Help for Diabetics, 2007
Contemporary reporting on Diabetech, wireless glucose data, rules, and patient-to-caregiver connectivity.
- Government recordTexas House Research Organization · HB 984 bill analysis, 2005
Lists Kevin McMahon of Diabetech in the witness record supporting diabetes self-care legislation. It documents participation rather than sole responsibility for policy change.
The LC-FAOD source establishes conference-abstract co-authorship and disease-monitoring research context. It does not establish pivotal treatment outcomes.